Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- New York, New York
- Most recent report
- 8-K, filed Sep 8, 2026
- Incorporated
- Delaware
- Filings on record
- 73 filings
- On EDGAR
- CIK 2081043
- Fiscal year ends
- December
- Filer status
- Emerging growth company
Financials 3
News 8 of 12
Prospectuses and Registrations 6
- S-3ASR Automatic shelf registration Mar 9, 2026
- S-8 Registration statement for an employee plan Mar 6, 2026
- S-8 POS Post-effective amendment to an employee plan registration Dec 31, 2025
- 424B3 Prospectus supplement for an offering Oct 27, 2025
- 424B3 Prospectus supplement for an offering Sep 24, 2025
- S-4 Registration statement for a merger or exchange Sep 22, 2025
Proxies 8 of 14
Ownership 8 of 31
- SCHEDULE 13G Large holder reported a passive stake Jul 27, 2026
- SCHEDULE 13D/A Large holder reported an active stake, amended Jul 17, 2026
- 4 Insider reported a trade Jul 9, 2026
- 144 Notice of a proposed sale of restricted stock Jul 7, 2026
- 4 Insider reported a trade Jun 29, 2026
- 4 Insider reported a trade Jun 29, 2026
- 144 Notice of a proposed sale of restricted stock Jun 26, 2026
- 144 Notice of a proposed sale of restricted stock Jun 25, 2026
Other 7
Everything here comes from AtaiBeckley Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.